Khetarpal V, Herbst T, Dominguez C, Munoz-Sanjuan I, Sampaio C, Marks B
J Huntingtons Dis. 2025; 14(1):85-92.
PMID: 39906760
PMC: 7617368.
DOI: 10.1177/18796397241301761.
Baran H, Jan Pietryja M, Kepplinger B
Biomolecules. 2025; 15(1).
PMID: 39858468
PMC: 11764436.
DOI: 10.3390/biom15010074.
Staats Pires A, Krishnamurthy S, Sharma S, Chow S, Klistorner S, Guillemin G
Neurol Neuroimmunol Neuroinflamm. 2025; 12(2):e200372.
PMID: 39823555
PMC: 11744609.
DOI: 10.1212/NXI.0000000000200372.
Zeng G, Krishnamurthy S, Staats Pires A, Guller A, Chaganti J, Tun N
Hepatol Commun. 2025; 8(12.
PMID: 39774873
PMC: 11567712.
DOI: 10.1097/HC9.0000000000000559.
Tamimou R, Montout C, Mura T, Conejero I, Evrard A, Courtet P
Brain Behav Immun Health. 2024; 42:100903.
PMID: 39650284
PMC: 11625281.
DOI: 10.1016/j.bbih.2024.100903.
Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction.
Wilson E, Umans J, Swarovski M, Minhas P, Midttun O, Ulvik A
Res Sq. 2024; .
PMID: 39399688
PMC: 11469709.
DOI: 10.21203/rs.3.rs-4980210/v1.
Computed Tomography and Fluorescence Spectroscopy Blood Plasma Analysis Study for Kynurenic Acid as a Diagnostic Approach to Chronic Coenurosis in Sheep.
Olar L, Tomoiaga V, Marza S, Papuc I, Beteg I, Pestean P
Life (Basel). 2024; 14(9).
PMID: 39337904
PMC: 11433226.
DOI: 10.3390/life14091121.
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities.
Pocivavsek A, Schwarcz R, Erhardt S
Pharmacol Rev. 2024; 76(6):978-1008.
PMID: 39304346
PMC: 11549936.
DOI: 10.1124/pharmrev.124.000239.
The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects.
Alves L, Moore J, Kell D
Int J Mol Sci. 2024; 25(16).
PMID: 39201768
PMC: 11354673.
DOI: 10.3390/ijms25169082.
The Tryptophan Metabolite Indole-3-Propionic Acid Raises Kynurenic Acid Levels in the Rat Brain In Vivo.
Sathyasaikumar K, Blanco-Ayala T, Zheng Y, Schwieler L, Erhardt S, Tufvesson-Alm M
Int J Tryptophan Res. 2024; 17:11786469241262876.
PMID: 38911967
PMC: 11191616.
DOI: 10.1177/11786469241262876.
MM165 - A Small Hybrid Molecule Modulates the Kynurenine Pathway and Attenuates Lipopolysaccharide-Induced Memory Deficits and Inflammation.
Kotanska M, Lanocha M, Bednarski M, Marcinkowska M
Neurochem Res. 2024; 49(5):1200-1211.
PMID: 38381245
DOI: 10.1007/s11064-024-04105-z.
Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients.
Markovic M, Petronijevic N, Stasevic M, Stasevic Karlicic I, Velimirovic M, Stojkovic T
Cells. 2023; 12(24).
PMID: 38132134
PMC: 10741951.
DOI: 10.3390/cells12242814.
Molecular mechanisms underlying physical exercise-induced brain BDNF overproduction.
Cefis M, Chaney R, Wirtz J, Meloux A, Quirie A, Leger C
Front Mol Neurosci. 2023; 16:1275924.
PMID: 37868812
PMC: 10585026.
DOI: 10.3389/fnmol.2023.1275924.
Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression.
Lullau A, Haga E, Ronold E, Dwyer G
Front Neurosci. 2023; 17:1223145.
PMID: 37614344
PMC: 10442706.
DOI: 10.3389/fnins.2023.1223145.
Altered gut microbiota profile in patients with perimenopausal panic disorder.
Lin S, Wang H, Qiu J, Li M, Gao E, Wu X
Front Psychiatry. 2023; 14:1139992.
PMID: 37304433
PMC: 10249373.
DOI: 10.3389/fpsyt.2023.1139992.
Kynurenine promotes Calcitonin secretion and reduces cortisol in the Japanese flounder Paralichthys olivaceus.
Ikari T, Furusawa Y, Tabuchi Y, Maruyama Y, Hattori A, Kitani Y
Sci Rep. 2023; 13(1):8700.
PMID: 37248272
PMC: 10227051.
DOI: 10.1038/s41598-023-35222-4.
First trimester human umbilical cord perivascular cells (HUCPVC) modulate the kynurenine pathway and glutamate neurotransmission in an LPS-induced mouse model of neuroinflammation.
Siddiqui F, Gallagher D, Shuster-Hyman H, Lopez L, Gauthier-Fisher A, Librach C
J Inflamm (Lond). 2023; 20(1):15.
PMID: 37127610
PMC: 10152638.
DOI: 10.1186/s12950-023-00340-3.
A unified model of the biology of peripartum depression.
Levin G, Ein-Dor T
Transl Psychiatry. 2023; 13(1):138.
PMID: 37117197
PMC: 10147643.
DOI: 10.1038/s41398-023-02439-w.
Inflammation, stress and depression: An exploration of ketamine's therapeutic profile.
Johnston J, Greenwald M, Henter I, Kraus C, Mkrtchian A, Clark N
Drug Discov Today. 2023; 28(4):103518.
PMID: 36758932
PMC: 10050119.
DOI: 10.1016/j.drudis.2023.103518.
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment.
Johnston J, Kadriu B, Allen J, Gilbert J, Henter I, Zarate Jr C
Neuropharmacology. 2023; 226:109422.
PMID: 36646310
PMC: 9983360.
DOI: 10.1016/j.neuropharm.2023.109422.